Bicycle Therapeutics Email Formats

Biotechnology Research • Cambridge, England, United Kingdom • 201-500 Employees

Bicycle Therapeutics Email Formats

Bicycle Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@bicycletx.com), used 93.2% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@bicycletx.com	93.2%
{first initial}.{last name}	j.doe@bicycletherapeutics.com	4.4%
{first initial}.{last name}	j.doe@bicycletx.com	2.4%

Overview About Employees Insights Funding Tech Stack Trending Companies FAQ

Company overview

Headquarters	Granta Park, Cambridge, England CB21 6GP, GB
Phone number	+441223261503
Websites	bicycletherapeutics.com bicycletx.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Drug Discovery, Phage Display, Peptide Therapeutics
Founded	2009
Employees	201-500
Socials

About Bicycle Therapeutics

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC molecule targeting EphA2, a historically undruggable target; and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) targeting Nectin-4 and agonizing CD137, in company-sponsored clinical trials. Additionally, the company is developing Bicycle® Radio Conjugates (BRC™) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle® technology to develop therapies for diseases beyond oncology. Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, MA.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Director

Entry

Manager

Employees by Department

Bicycle Therapeutics has 176 employees across 15 departments.

Departments

Number of employees

Funding Data

Explore Bicycle Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-12	14	$200,000,000
2024-06-23	14	$555,000,000

Funding Insights

$755,000,000

Total funding amount

$555,000,000

Most recent funding amount

Number of funding rounds

Bicycle Therapeutics Tech Stack

Discover the technologies and tools that power Bicycle Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery CDN

CDN

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Draftpress HFCM

WordPress plugins

Frequently asked questions

Bicycle Therapeutics is located in Cambridge, England, GB.

You can reach Bicycle Therapeutics at +441223261503.

Bicycle Therapeutics was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Bicycle Therapeutics has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

Bicycle Therapeutics has raised a total of $755,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Bicycle Therapeutics

Michael Skynner

Chief Technology Officer

@bicycletx.com

4.8

40,000 users